Your browser doesn't support javascript.
loading
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma.
Suzuki, Takeshi; Okamura, Akihiko; Watanabe, Masayuki; Mine, Shinji; Imamura, Yu; Asari, Takao; Osumi, Hiroki; Nakayama, Izuma; Ichimura, Takashi; Ogura, Mariko; Ooki, Akira; Takahari, Daisuke; Yamaguchi, Kensei; Chin, Keisho.
Afiliação
  • Suzuki T; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Okamura A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
  • Watanabe M; Department of Gastroenterological Surgery, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. akihiko.okamura@jfcr.or.jp.
  • Mine S; Department of Gastroenterological Surgery, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Imamura Y; Department of Gastroenterological Surgery, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Asari T; Department of Gastroenterological Surgery, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Osumi H; Department of Radiation Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nakayama I; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ichimura T; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ogura M; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Ooki A; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Takahari D; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yamaguchi K; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Chin K; Department of Gastroenterological Medicine, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Ann Surg Oncol ; 27(5): 1510-1517, 2020 May.
Article em En | MEDLINE | ID: mdl-31820213
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Serpinas / Esofagectomia / Terapia Neoadjuvante / Carcinoma de Células Escamosas do Esôfago / Linfonodos / Antígenos de Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioterapia / Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Serpinas / Esofagectomia / Terapia Neoadjuvante / Carcinoma de Células Escamosas do Esôfago / Linfonodos / Antígenos de Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article